Dose Duration Optimization LIFU
Brief description of study
Obsessive-compulsive disorder (OCD) is a serious mental health condition that affects approximately 2.2 million adults in the United States. People with OCD experience unwanted, intrusive thoughts (obsessions) and feel compelled to perform repetitive behaviors (compulsions). This study is a randomized, sham-controlled trial evaluating the safety, tolerability, and target engagement of multi-session subthalamic nucleus (STN)-targeted low-intensity focused ultrasound (LIFU) in adults with OCD. Twenty participants will be randomized to receive either active or sham LIFU delivered via the ATTN201 wearable device (Attune Neurosciences) twice weekly over up to 8 sessions. All participants will undergo MRI at baseline and at three checkpoints. The study will evaluate two treatment course durations (4 sessions and 8 sessions of LIFU).
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 99 years or below
-
Gender: All
TBD
Find a site
,
Send a message
Enter your contact details to connect with study team
Primary Contact
Interested in the study
Select a study center that’s convenient for you, and get in touch with the study team.
Contact a study centerPlease choose between Voice or SMS based delivery of verification code
or